Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.46
$0.096.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -170.49% | 14.91% | 11.18% | 106.45% | 78.92% |
| Total Depreciation and Amortization | 11.00% | 10.77% | 10.53% | 8.47% | 8.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.77% | 20.80% | 96.64% | -12.46% | -67.64% |
| Change in Net Operating Assets | 107.77% | 87.01% | 99.29% | -68.60% | -243.89% |
| Cash from Operations | 5.87% | 30.46% | 50.27% | 115.41% | 47.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | 0.00% | -- | -- |
| Cash from Investing | -- | 100.00% | 0.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.87% | -- | 65.63% | -99.62% | -15.87% |
| Repurchase of Common Stock | -- | -23.16% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98.55% | -1,225.99% | 57.02% | -99.72% | -15.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 530.71% | 28.27% | 94.69% | -92.11% | 155.25% |